ROS‐Responsive Eye Drop for Controlled Release of 20‐Deoxyingenol Improves Diabetic Corneal Healing by Activating Macrophage Autophagy and Metabolic Reprogramming
Advanced Science · 2026-11 · 13 (62)
DOI: 10.1002/advs.77232 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 18.08.2026. Verfasst von Jiaxin Wu und 20 weiteren Autor:innen. Beteiligte Einrichtung: International Ocular Surface Research Center, Institute of Ophthalmology, Key Laboratory for Regenerative Medicine, Jinan University, Guangzhou, Chin…. Hauptthemen laut MEDLINE: Autophagy, Reactive Oxygen Species, Wound Healing, Macrophages. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China Cross-disciplinary Major Research Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
Impaired corneal wound healing in diabetes remains a major clinical challenge, driven by defective autophagy, metabolic dysregulation, and sustained inflammation within a high‐reactive oxygen species (ROS) microenvironment. Here, we engineered a ROS‐responsive ocular delivery system based on N1‐(4‐boronobenzyl)‐N3‐(4‐boronophenyl)‐N1, N1, N3, N3‐tetramethylpropane‐1,3‐diaminium (TSPBA)/poly(vinyl alcohol) (PVA) hydrogel microspheres (TP hydrogel microspheres) encapsulating 20‐deoxyingenol (20‐DOI), which enables sustained and ROS‐triggered drug release. Under high‐glucose conditions in vitro, which were used to model a diabetic microenvironment associated with elevated oxidative stress, TP/20‐DOI microspheres promoted macrophage polarization from the M1 phenotype toward the M2 phenotype. Transcriptomic and metabolic analyses indicated that this shift was driven by enhanced autophagy and concurrent metabolic rewiring from glycolysis to oxidative phosphorylation. In streptozotocin‐induced diabetic mice with corneal abrasions, topical TP/20‐DOI microspheres significantly accelerated re‐epithelialization and nerve regeneration while attenuating inflammation. The mechanism involved the autophagy‐dependent suppression of macrophage M1 polarization, which diminished the levels of macrophage‐derived C‐X‐C motif chemokine ligand 3 (CXCL3)/CXCL5 and neutrophil infiltration, as evidenced by the reversal of these effects upon pharmacological autophagy inhibition. Our findings establish an “autophagy–metabolism–polarization” axis as the core mechanism through which the microenvironment‐responsive TP/20‐DOI microspheres coordinate diabetic corneal repair, providing a blueprint for immunometabolic reprogramming therapies in ROS‐driven diabetic complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- International Ocular Surface Research Center, Institute of Ophthalmology, Key Laboratory for Regenerative Medicine, Jinan University, Guangzhou, China.
- Department of Ophthalmology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
- Department of Immunology & Institute of Geriatric Immunology, School of Medicine, Jinan University, Guangzhou, China.
- Guangdong-Hong Kong-Macau Great Bay Area Geroscience Joint Laboratory, School of Medicine, Jinan University, Guangzhou, China.
- Institute of Genomic Medicine, College of Pharmacy, Jinan University, Guangzhou, China.
- Department of Ophthalmology, Guangzhou First People's Hospital, Guangzhou, Guangdong, China.
ORCID-Profile: Weihan Zheng, Zhijie Li, Guobing Chen, Shiyu Li, Jun Liu
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China Cross-disciplinary Major Research Program
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Foundation of China
- Science and Technology Project in Guangzhou
- Nonprofit Central Research Institute Fund of the Chinese Academy of Medical Sciences
- Fundamental Research Funds for the Central Universities
- Changzhi Medical College "1+1" Scientific Research Collaboration
Zitieren
APA
Wu, J., Chen, W., Qiu, H., Zheng, W., Jiao, Y., Du, J., Zhuang, Z., Hua, X., Gu, J., Liu, Y., Li, Z., Xie, J., Sun, H., Lan, H., Sun, X., Xue, Y., Fu, T., Li, Z., Chen, G., …, & Liu, J. (2026). ROS‐Responsive Eye Drop for Controlled Release of 20‐Deoxyingenol Improves Diabetic Corneal Healing by Activating Macrophage Autophagy and Metabolic Reprogramming. Advanced Science, 13(62). https://doi.org/10.1002/advs.77232
Vancouver
Wu J, Chen W, Qiu H, Zheng W, Jiao Y, Du J, et al. ROS‐Responsive Eye Drop for Controlled Release of 20‐Deoxyingenol Improves Diabetic Corneal Healing by Activating Macrophage Autophagy and Metabolic Reprogramming. Advanced Science. 2026;13(62). doi:10.1002/advs.77232
BibTeX
@article{Wu2026,
author = {Wu, Jiaxin and Chen, Wanying and Qiu, Haijiang and Zheng, Weihan and Jiao, Ying and Du, Jingheng and Zhuang, Zhudan and Hua, Xing and Gu, Jingyi and Liu, Yuheng and Li, Zhaojin and Xie, Jingbin and Sun, Hanxiao and Lan, Huifei and Sun, Xin and Xue, Yunxia and Fu, Ting and Li, Zhijie and Chen, Guobing and Li, Shiyu and Liu, Jun},
title = {ROS‐Responsive Eye Drop for Controlled Release of 20‐Deoxyingenol Improves Diabetic Corneal Healing by Activating Macrophage Autophagy and Metabolic Reprogramming},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {62},
doi = {10.1002/advs.77232}
}
EUVIMED